Sam-A Pharm. Co., Ltd (KOSDAQ: 009300)

Sam-A Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18,573	9,019	9,176	7,984	18,396	12,998
Short-Term Investments	48,638	61,638	68,638	45,638	29,911	18,741
Trading Asset Securities	7,300	8,447	3,197	-	16,048	18,185
Cash & Short-Term Investments	74,512	79,104	81,011	53,623	64,354	49,924
Cash Growth	-10.58%	-2.35%	51.08%	-16.68%	28.90%	8.56%
Accounts Receivable	24,600	22,596	21,466	18,039	15,418	21,963
Other Receivables	2,987	3,079	2,025	1,293	1,878	2,404
Receivables	27,587	25,675	23,491	19,332	17,296	24,367
Inventory	14,346	13,013	12,244	9,341	12,157	11,225
Prepaid Expenses	-	160.76	71.14	44.88	47.44	40.16
Other Current Assets	360.17	38.37	40.27	13.96	11.46	-0
Total Current Assets	116,805	117,992	116,856	82,355	93,866	85,556
Property, Plant & Equipment	41,625	40,511	37,164	40,188	43,412	46,274
Long-Term Investments	75,795	61,362	42,957	60,434	36,951	50,546
Other Intangible Assets	4,164	4,295	4,394	5,537	6,276	6,497
Long-Term Deferred Tax Assets	464.39	80.27	1,041	-	578.59	794.46
Other Long-Term Assets	7,105	7,067	786.49	657.77	1,024	1,114
Total Assets	245,958	231,308	203,198	189,172	182,106	190,781
Accounts Payable	6,868	5,002	7,040	3,772	2,562	3,894
Accrued Expenses	-	2,229	1,745	15.74	11.05	3.4
Current Portion of Long-Term Debt	2,556	1,667	-	2,407	-	-
Current Portion of Leases	1,833	1,858	1,725	1,709	1,783	1,745
Current Income Taxes Payable	5,273	3,542	4,386	1,580	348.9	2,030
Other Current Liabilities	8,003	6,847	6,662	5,111	4,762	7,127
Total Current Liabilities	24,532	21,145	21,558	14,594	9,468	14,799
Long-Term Debt	2,556	2,500	-	-	2,407	2,407
Long-Term Leases	4,920	5,645	45	1,509	3,015	4,328
Long-Term Deferred Tax Liabilities	12.05	12.05	12.05	175.08	-	-
Other Long-Term Liabilities	1,545	1,536	964.81	868.76	917.34	973.8
Total Liabilities	33,564	30,838	22,580	17,147	15,819	22,631
Common Stock	6,370	6,370	6,370	6,370	6,370	6,370
Additional Paid-In Capital	14,413	14,413	14,413	14,413	14,413	14,413
Retained Earnings	190,337	179,204	160,354	149,836	147,812	149,436
Treasury Stock	-1,513	-1,513	-1,513	-1,513	-1,513	-1,513
Comprensive Income & Other	2,786	1,996	992.92	2,917	-795.91	-557.25
Shareholders' Equity	212,394	200,470	180,618	172,024	166,287	168,150
Total Liabilities & Equity	245,958	231,308	203,198	189,172	182,106	190,781
Total Debt	11,864	11,669	1,770	5,625	7,206	8,479
Net Cash (Debt)	62,648	67,435	79,241	47,998	57,148	41,444
Net Cash Growth	-20.48%	-14.90%	65.09%	-16.01%	37.89%	-9.87%
Net Cash Per Share	7665.69	11048.85	12983.19	7864.24	9363.43	6790.45
Filing Date Shares Outstanding	6.1	6.1	6.1	6.1	6.1	6.1
Total Common Shares Outstanding	6.1	6.1	6.1	6.1	6.1	6.1
Working Capital	92,273	96,848	95,298	67,761	84,398	70,757
Book Value Per Share	34799.62	32845.97	29593.28	28185.26	27245.20	27550.41
Tangible Book Value	208,230	196,175	176,224	166,488	160,011	161,652
Tangible Book Value Per Share	34117.43	32142.19	28873.32	27278.10	26216.95	26485.88
Land	-	4,346	9,343	9,343	9,343	9,343
Buildings	-	30,472	30,445	30,445	30,445	30,445
Machinery	-	24,791	23,856	24,141	23,879	23,397
Construction In Progress	-	1,174	45.73	4.03	4.03	29.83

Source: S&P Capital IQ. Standard template. Financial Sources.